Mantegazza R, Wolfe GI, Muppidi S, Wiendl H, Fujita KP, O’Brien FL, Booth HDE, Howard Jr JF, REGAIN Study Group (2021) Post-intervention status in patients with refractory myasthenia gravis treated with eculizumab during REGAIN and its open-label extension. Neurology 96:e610–e618. https://doi.org/10.1212/WNL.0000000000011207

Article  CAS  Google Scholar 

Utsugisawa K, Nagane Y, Akaishi T, Suzuki Y, Imai T, Tsuda E, Minami N, Uzawa A, Kawaguchi N, Masuda M, Konno S, Suzuki H, Murai H, Aoki M (2017) Early fast-acting treatment strategy generalized myasthenia gravis. Muscle Nerve 55:794–801. https://doi.org/10.1002/mus.253973

Article  PubMed  PubMed Central  Google Scholar 

Howard JF (2018) Myasthenia gravis: the role of complement at the neuromuscular junction. Ann N Y Acad Sci 1412:113–128. https://doi.org/10.1111/nyas.13522

Article  ADS  CAS  PubMed  Google Scholar 

Dhillon S (2018) Eculizumab: a review in generalized myasthenia gravis Mar. Drugs 78:367–376. https://doi.org/10.1007/s40265-018-0875-9

Article  CAS  PubMed  PubMed Central  Google Scholar 

Howard JF, Utsugisawa K, Benatar M, Murai H, Barohn RJ, Illa I, Jacob S, Vissing J, Burns TM, Kissel JT, Muppidi S, Nowak RJ, O’Brien F, Wang JJ, Mantegazza R, REGAIN study group (2017) Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalized myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study. Lancet Neurol 16:976–987. https://doi.org/10.1016/S1474-4422(17)30369-1

Yanagidaira M, Nishida Y, Yokota T (2020) Temporal correlation between serum CH50 level and symptom severity of myasthenia gravis during eculizumab therapy. Clin Neurol Neurosurg 189:105630. https://doi.org/10.1016/j.clineuro.2019.105630

Article  PubMed  Google Scholar 

Howard JF, Karam C, Yountz M, O’Brien FL, Mozaffar T for the REGAIN Study Group (2021) Long-term efficacy of eculizumab in refractory generalized myasthenia gravis: responder analyses. Ann Clin Transl Neurol 8:1398–1407. https://doi.org/10.1002/acn3.51376

Article  CAS  Google Scholar 

Usman U, Chrisman C, Houston D, Haws CC, Wang A, Muley S (2021) The use of eculizumab in ventilator-dependent myasthenia gravis patients. Muscle Nerve 64:212–215. https://doi.org/10.1002/mus.27326

Article  CAS  PubMed  Google Scholar 

Akaaboune M, Culican SM, Turney SG, Lichtman JW (1999) Rapid and reversible effects of activity on acetylcholine receptor density at the neuromuscular junction in vivo. Science 286:503–507. https://doi.org/10.1126/science.286.5439.503

Article  CAS  PubMed  Google Scholar 

Bruneau EG, Macpherson PC, Goldman D, Hume RI, Akaaboune M (2005) The effect of agrin and laminin on acetylcholine receptor dynamics in vitro. Dev Biol 288:248–258. https://doi.org/10.1016/j.ydbio.2005.09.041

Article  CAS  PubMed  Google Scholar 

Pham MC, Masi G, Patzina R, Obaid AH, Oxendine SR, Oh S, Payne AS, Nowak RJ, O’Connor KC (2023) Individual myasthenia gravis autoantibody clones can efficiently mediate multiple mechanisms of pathology. Acta Neuropathol 146:319–336. https://doi.org/10.1007/s00401-023-02603-y

Article  CAS  PubMed  Google Scholar 

Maurer M, Bougoin S, Feferman T, Frenkian M, Bismuth J, Mouly V, Clairac G, Tzartos S, Fadel E, Eymard B, Fuchs S, Souroujon MC, Berrih-Aknin S (2015) IL-6 and Akt are involved in muscular pathogenesis in myasthenia gravis. Acta Neuropathol Commun 3:1. https://doi.org/10.1186/s40478-014-0179-6

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tüzün E, Huda R, Christadoss P (2011) Complement and cytokine based therapeutic strategies in myasthenia gravis. J Autoimmun 37:136–143. https://doi.org/10.1016/j.jaut.2011.05.006

Article  CAS  PubMed  Google Scholar 

Molin CJ, Westerberg E, Punga AR (2017) Profile of upregulated inflammatory proteins in sera of Myasthenia Gravis patients. Sci Rep 7:39716. https://doi.org/10.1038/srep39716

Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

Vilquin JT, Bayer AC, Le Panse R, Berrih-Aknin S (2019) The muscle is not a passive target in myasthenia gravis. Front Neurol 10:1343. https://doi.org/10.3389/fneur.2019.01343

Article  PubMed  PubMed Central  Google Scholar